International Stem Cell Corp (ISCO) financial statements (2021 and earlier)

Company profile

Business Address 5950 PRIESTLY DRIVE
CARLSBAD, CA 92008
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 100112
Cash and cash equivalents 100112
Receivables 101100
Inventory, net of allowances, customer advances and progress billings 211121
Inventory 211121
Deferred costs      0
Deferred tax assets   000
Other undisclosed current assets 110000
Total current assets: 432345
Noncurrent Assets
Inventory, Noncurrent 1110  
Property, plant and equipment 000011
Intangible assets, net (including goodwill) 333332
Intangible assets, net (excluding goodwill) 333332
Other undisclosed noncurrent assets 000000
Total noncurrent assets: 445443
TOTAL ASSETS: 877778
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 111222
Accounts payable 011111
Accrued liabilities 110121
Due to related parties 2  300
Deferred revenue and credits    0
Other undisclosed current liabilities 232045
Total current liabilities: 554677
Noncurrent Liabilities
Liabilities, other than long-term debt 0   00
Deferred rent credit 0
Deferred tax liabilities, net    00
Total noncurrent liabilities: 0   00
Total liabilities: 554677
Stockholders' equity
Stockholders' equity attributable to parent, including: 32320(4)
Common stock 000000
Additional paid in capital 109107102999578
Accumulated deficit (107)(105)(98)(97)(95)(82)
Other undisclosed stockholders' equity attributable to parent 00000 
Total stockholders' equity: 32320(4)
Other undisclosed liabilities and equity     (0)5
TOTAL LIABILITIES AND EQUITY: 877778

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues 1177876
Revenue, net77876
Cost of revenue (4)(2)(2)(2)(2)(2)
Cost of goods and services sold     (0)(0)
Financial services costs (1) (1)(1)
Gross profit: 755555
Operating expenses (10)(10)(10)(10)(14)(12)
Other undisclosed operating income     00
Operating loss: (3)(5)(5)(5)(9)(8)
Nonoperating income (expense) 1(1)42(4)(3)
Interest and debt expense (0)(0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes      0
Loss from continuing operations before equity method investments, income taxes: (2)(6)(1)(3)(12)(10)
Other undisclosed income from continuing operations before income taxes 00000 
Net loss available to common stockholders, diluted: (2)(6)(1)(3)(12)(10)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss: (2)(6)(1)(3)(12)(10)
Comprehensive loss, net of tax, attributable to parent: (2)(6)(1)(3)(12)(10)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: